Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil liposome injection in lower extremity arteriosclerosis obliterans
CTR20180050Phase 2Active
- Sponsor
- Shanghai Modern Pharmaceutical Formulation Engineering Research Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in arteriosclerosis obliterans, sponsored by Shanghai Modern Pharmaceutical Formulation Engineering Research Center. Started Feb 2018; status: active.
02
Drugs
Vasostenoon
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on CTR20180050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180050.